About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

AGM Chairman and CEO Addresses

May 31, 2017

Click here to read more

Post navigation

Mylan Arbitration Update – expert report on quantum of damages claimed filed

2017 AGM Resuls

Related Posts

Phosphagenics Licencing Agreement Update

September 10, 2018

Avecho investor update – webinar recording

June 25, 2020June 25, 2020

AGM Chairman’s Address and CEO Presentation

May 28, 2018

Recent Posts

Ethics Approval for CBD Topical Osteoarthritis Study
October 21, 2021
Dosing commences for Phase I human clinical trial
October 4, 2021
Biotech Webinar
September 23, 2021

Categories

Analyst Coverage
Company Announcement
Company Report
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.